![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines: a commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop
-
Article
The need for education in pharmacogenomics: a regulatory perspective
-
Article
Pharmacogenomic-guided drug development: regulatory perspective
-
Article
Erratum to: Individual bioequivalence: new concepts in the statistical assessment of bioequivalence metrics
-
Article
Bioequivalence assessment of generic drugs: an American point of view
-
Article
Workshop III Report: Scaleup of Liquid and Semisolid Disperse Systems
-
Article
Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration
The protein binding of salicylate was measured by continuous ultrafiltration (diafiltration) at 22°C in serum obtained from 5 healthy young (mean age: 27 years) and 5 healthy elderly (mean age: 73 years) male ...
-
Article
1230 The Pharmacokinetics of Phenobarb and Phenytoln in Neonates
The pharmacokinetics of Phenobarb and Phenytoin were evaluated in 14 neonatal patients. The average gestational age at birth was 32 (±5) weeks range, 26-41 weeks. The average post-conceptual age was 33 (±6) we...